2022 American Diabetes Association Standards of Care
Join Know Diabetes by Heart™ for a presentation on the Standards of Medical Care in Diabetes—2022 (Standards of Care) from the American Diabetes Association® (ADA).
Date: Wednesday, February 2, 2022
Time: 4:00 pm
– 5:00 pm ET
Join Know Diabetes by Heart™ for a presentation on the Standards of Medical Care in Diabetes—2022 (Standards of Care) from the American Diabetes Association® (ADA). Dr. Nuha El Sayed will highlight important updates to this year’s Standards of Care and how those changes impact clinical care, especially as they related to type 2 diabetes and cardiovascular disease.
Learning Objectives:
- Identify the ADA’s 2022 Standards of Care for classifying, diagnosing, and treating diabetes and cardiovascular disease.
Nuha Ali El Sayed, MD, MM Sc., Vice President, American Diabetes Association and Instructor in Medicine, Harvard Medical School
Know Diabetes by Heart™ Presents: The Link Between Diabetes and Coronary Artery Disease
Join us to learn about the latest guidelines for treating patients with diabetes and coronary artery disease.
Date: Tuesday, February 15, 2022
Time: 2:00 pm
– 3:00 pm ET
In December 2021, Get With The Guidelines®-Coronary Artery Disease (GWTG-CAD) enhanced data collection and monitoring of care for patients with diabetes. Learn about the science behind these changes, and to take a closer look at the link between diabetes and coronary artery disease. The webinar will feature distinguished speaker Tracy Yu-Ping Wang, MD, MHS, MSc, FAHA, FACC, Professor of Medicine in Cardiology at Duke University.
Tracy Yu-Ping Wang, MD, MHS, MSc, FAHA, FACC Professor of Medicine in Cardiology at Duke University
Implementation of Guideline-Based Care in the Hospital Setting
Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.
Episode 4 – Implementation of Guideline-Based Care in the Hospital Setting
Jennifer B. Green, MD is a professor of medicine and endocrinologist at Duke University and the Duke Clinical Research Institute (DCRI). Her research has focused upon strategies to treat diabetes and reduce the risk of cardiovascular, renal and other complications. Her work with the DCRI has included leadership of several international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, and Harmony Outcomes), and she is now the US coordinating center PI for the EMPA-Kidney trial. Dr. Green is also a member of the ADA Professional Practice Committee, which publishes the annual Standards of Care in Diabetes.
Jennifer B. Green, MD
Neha J. Pagidipati, MD, MPH is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is also building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity.
Neha J. Pagidipati, MD, MPH
American Diabetes Association Scientific Sessions Recap – Latest Research on CVD and Diabetes including Renal Risk Management
Date: Tuesday, July 27, 2021
Time: 3:00 pm
– 4:00 pm ET
Join Know Diabetes By Heart for an expert panel discussion on new science released at the 81st American Diabetes Association’s Scientific Sessions. Panelists will discuss clinical highlights from the 2021 Scientific Sessions related to cardiovascular disease and renal risk management. As experts in their field, they will also relate how new findings can be incorporated into clinical practice and how to apply clinically relevant highlights to improve patient outcomes.
Jennifer Green, MD (Professor of Medicine, Duke University Department of Medicine)
Sanjay, Kaul, MD, FACC, FAHA (Professor of Medicine, Cedars-Sinai Medical Center)
Neda Rasouli, MD (Professor of Medicine, University of Colorado)
American Diabetes Association’s 2021 Standards of Care and Implications for Practice
Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.
ADA’s 2021 Standards of Care and Implications for Practice
Boris Draznin, MD, PhD is the Celeste and Jack Grynberg Professor of Medicine and Director of the Adult Diabetes Program at the University of Colorado Anschutz Medical Campus. He is a member of the American Diabetes Association, The Endocrine Society, the American Society for Clinical Investigation, and the Association of American Physicians. Dr. Draznin has published over 160 scientific articles and has written or edited over 30 books and book chapters.
Pamela R. Kushner, MD, FAAFP is a board-certified family medicine doctor at the Kushner Wellness Center in Los Alamitos, California, and a Clinical Professor in the Department of Family Medicine at the University of California (UC), Irvine Medical Center. She has served on the AAFP Women’s Health, Drugs and Devices, Communication and FDA MedWatch committees. She has received awards in medical education and from the American Lung Association.
2020 ADA Standards of Care and Implications for Practice
Listen to Dr. Jennifer Green, an endocrinologist and diabetes and metabolism specialist and Dr. David Aguilar, a cardiologist and board certified in internal medicine, discuss how the new American Diabetes Association’s 2020 Standards of Care have changed and implications for practice.
Dr. Jennifer Green is a professor of medicine in the division of endocrinology, metabolism, and nutrition at Duke University and a faculty member of the Duke Clinical Research Institute. Dr. Green’s research has focused primarily upon strategies to treat diabetes mellitus and reduce the risk of cardiovascular and other diabetes-related complications. She is currently a member of the American Diabetes Association’s Professional Practice Committee, which publishes the organization’s annual Standards of Care in Diabetes.
Jennifer Green, MD
Dr. David Aguilar is an Associate Professor of Medicine in the Division of Cardiology at the University of Texas Health Science Center McGovern Medical School in Houston and in the Department of Epidemiology, Human Genetics, and Environmental Sciences at the University of Texas School of Public Health. Dr. Aguilar is a member of the American Heart Association/American Diabetes Association’s Know Diabetes by Heart Science Advisory Group. His research interests have predominantly focused on the impact of cardiometabolic disorders (including type 2 diabetes mellitus) on health outcomes. He has been the principal investigator and co-investigator in multiple grants from the National Institutes of Health and has been actively involved in clinical trials testing new treatment strategies in cardiovascular disease. He has also been an associate editor and on the editorial board of several cardiovascular journals.
David Aguilar, MD
AHA 2018 Cholesterol Guidelines
For people with diabetes, blood glucose isn’t the only important factor to track. New guidelines suggest the more than 110 million U.S. adults with diabetes or prediabetes should also manage their cholesterol as well as their blood glucose. Drs. Ronald Goldberg and Robert Eckel discuss the new American Heart Association’s 2018 Cholesterol Guidelines, released in November 2018 and the implications for type 2 diabetes along with pharmacotherapy and lifestyle interventions (2018 AHA Cholesterol Guidelines – Top Ten Things To Know).
Episode 3 – American Heart Association’s 2018 Cholesterol Guidelines and the Implications for Type 2 Diabetes
Ronald Goldberg, MD is a Professor of Medicine, Biochemistry, and Molecular Biology in the Division of Endocrinology, Diabetes and Metabolism at the University of Miami Miller School of Medicine. His research interests are in the prevention and early phases of development of diabetes and its complications with a special focus on the evolution of cardiovascular risk and disease in diabetes and in the metabolism and clinical relevance of HDL. His clinical and teaching interests are in the area of diabetes and lipid disorders.
Ronald Goldberg, MD
Robert Eckel, MD is a Distinguished Alumnus of the University of Cincinnati College of Medicine and currently the Charles A. Boettcher II Endowed Chair in Atherosclerosis, Professor of Medicine with appointments in the Division of Endocrinology, Metabolism and Diabetes, Division of Cardiology, and professor of Physiology and Biophysics at the University of Anschutz Medical Campus, and director of the Lipid Clinic at the University of Colorado Hospital. He also was a member of the Scientific Advisory Council of the National Institute of Diabetes, Digestive and Kidney Diseases at the National Institutes of Health. In addition, he served as President of the North American Association for the Study of Obesity and then president of the American Heart Association.
